What this means
This study is a trial that is still enrolling people, so no results are posted yet. It will test whether these supplements help muscle in adults 50 and older at high risk for muscle loss.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 50–99
- Where
- 1 site
The science
- Registered title
- Effects of Nutritional Supplementation of Leucine and Polyunsaturated Fatty Acids on Muscle Health in the Elderly
- Trial ID
- NCT06991855 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Sarcopenia, Sarcopenia in Elderly
- What is tested
- Animal-Based Oil Group, Plant-Based Oil Group
- Sponsor
- Chang Gung Memorial Hospital
- Ages
- 50 Years to 99 Years
- Dates
- First posted May 28, 2025 · updated Jun 22, 2025
Registry summary
Population aging has become a significant global concern, and Taiwan is set to officially enter the "super-aged society" in 2025. As individuals age, various physiological functions gradually decline, including a reduction in muscle mass, which is a key aspect of the aging process.
This interventional study aims to investigate the effects of leucine-rich protein combined with polyunsaturated fatty acid supplementation on middle-aged and elderly individuals (aged 50 and above) who are at high risk for sarcopenia.
Sites (1)
- Chang Gung Memorial Hospital, Linkou District, Taiwan